Global burden of benign prostatic hyperplasia, urinary tract infections, urolithiasis, bladder cancer, kidney cancer, and prostate cancer from 1990 to 2021

Hao Zi; Meng-Yang Liu; Li-Sha Luo; Qiao Huang; Peng-Cheng Luo; Hang-Hang Luan; Jiao Huang; Dan-Qi Wang; Yong-Bo Wang; Yuan-Yuan Zhang; Ren-Peng Yu; Yi-Tong Li; Hang Zheng; Tong-Zu Liu; Yu Fan; Xian-Tao Zeng

doi:10.1186/s40779-024-00569-w

Your Location：

Home >

Browse articles >

Global burden of benign prostatic hyperplasia, urinary tract infections, urolithiasis, bladder cancer, kidney cancer, and prostate cancer from 1990 to 2021

RESEARCH | Updated：2025-12-13

- Global burden of benign prostatic hyperplasia, urinary tract infections, urolithiasis, bladder cancer, kidney cancer, and prostate cancer from 1990 to 2021
- Global burden of benign prostatic hyperplasia, urinary tract infections, urolithiasis, bladder cancer, kidney cancer, and prostate cancer from 1990 to 2021
- “该研究报告了泌尿科领域的最新研究，对六种常见泌尿系统疾病的全球负担进行了全面评估。这项基于《2021年全球疾病负担》数据的研究表明，BPH和UTI是发病率和患病率的主要原因，而前列腺癌症的死亡率和DALY率最高。该研究还强调了高BMI和吸烟等风险因素对肾脏、膀胱和前列腺癌症死亡的影响，强调了国际合作改善疾病管理的必要性。”
- MMR 2025年12卷第7期页码：1007-1022
- Affiliations：
  
  1.Center for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan 430071, China
  2.Evidence-Based Medicine Center, Xiangyang No. 1 People’s Hospital, Hubei University of Medicine, Xiangyang 441000, Hubei, China
  3.Department of Urology, Wuhan Clinical Research Center of Tumors of the Urinary System and Male Genital Organs, Hubei Key Laboratory of Urinary System Diseases, Zhongnan Hospital of Wuhan University, Wuhan 430071, China
  4.Department of Urology, Wuhan Third Hospital, Tongren Hospital of Wuhan University, Wuhan 430060, China
  5.Department of Forensic Medicine, Zhongnan Hospital of Wuhan University, Wuhan 430071, China
  6.School of Clinical Medicine, Hubei University of Arts and Science, Xiangyang 441053, Hubei, China
  7.Department of Urology, Institute of Urology, Peking University First Hospital, Peking University, The National Urological Cancer Center of China, Beijing 100034, China
- Author bio：
  
  * zh-urology@whu.edu.cn
  liutongzu@163.com
  dantefanbmu@pku.edu.cn
  zengxiantao1128@whu.edu.cn
- Funds：
  
  the National Key Research and Development Program(2022YFC3600700);the Fundamental Research Funds for the Central Universities(2042024YXA008);the Young Top-Notch Talent Cultivation Program of Hubei Province (for Prof. Xian-Tao Zeng)
- DOI：10.1186/s40779-024-00569-w
  中图分类号：
- 纸质出版：2025-07
- Accepted：
Scan QR Code
Global burden of benign prostatic hyperplasia, urinary tract infections, urolithiasis, bladder cancer, kidney cancer, and prostate cancer from 1990 to 2021[J]. MMR, 2025,12(7):1007-1022.

Cite this article as: Zi H, Liu MY, Luo LS, Huang Q, Luo PC, Luan HH, et al. Global burden of benign prostatic hyperplasia, urinary tract infections, urolithiasis, bladder cancer, kidney cancer, and prostate cancer from 1990 to 2021. Mil Med Res. 2024;11(1):64.
Global burden of benign prostatic hyperplasia, urinary tract infections, urolithiasis, bladder cancer, kidney cancer, and prostate cancer from 1990 to 2021[J]. MMR, 2025,12(7):1007-1022. DOI： 10.1186/s40779-024-00569-w.

Cite this article as: Zi H, Liu MY, Luo LS, Huang Q, Luo PC, Luan HH, et al. Global burden of benign prostatic hyperplasia, urinary tract infections, urolithiasis, bladder cancer, kidney cancer, and prostate cancer from 1990 to 2021. Mil Med Res. 2024;11(1):64. DOI： 10.1186/s40779-024-00569-w.

浏览量

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

工具集

关联资源

Global, regional, and national burden of kidney, bladder, and prostate cancers and their attributable risk factors, 1990–2019

Performance of GPT-4 for automated prostate biopsy decision-making based on mpMRI: a multi-center evidence study

Global burden and cross-country inequalities in urinary tumors from 1990 to 2021 and predicted incidence changes to 2046

Salmonella enterica mediated epigenetic promotion of fibrosis is a novel factor in benign prostatic hyperplasia

Epidemiological trends of subarachnoid hemorrhage at global, regional, and national level: a trend analysis study from 1990 to 2021

Global burden of benign prostatic hyperplasia, urinary tract infections, urolithiasis, bladder cancer, kidney cancer, and prostate cancer from 1990 to 2021

Global burden of benign prostatic hyperplasia, urinary tract infections, urolithiasis, bladder cancer, kidney cancer, and prostate cancer from 1990 to 2021

DOI：10.1186/s40779-024-00569-w